Dasatinib

Dasatinib (Sprycel, BMS-354825) is an oral BCR-ABL, c-KIT, SRC inhibitor (IC50=<1, 79, and 0.8, respectively) and cancer drug developed by Bristol-Myers Squibb. FDA approved for treatment of chronic myelogenous leukemia (CML) and philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

Catalog No. Size Price Quantity
92-1183 10 mg $149.00

Please contact Customer Service at customerservicedrx@eurofins.com for European (EUR) or United Kingdom (GBP) pricing or log in to see your account-specific pricing.
Description
Dasatinib
Compound Type
Agonist
Storage
≤ -20◦C
Source
Synthetic
The above data is a representative example from a Eurofins DiscoverX cell-based assay that uses this ligand.